Get started
Author

Yusuke Shima

Phospholipid Membrane-Mediated Hemozoin Formation: The Effects of Physical Properties and Evidence of Membrane Surrounding Hemozoin
2013 · Nguyen Tien Huy, Yusuke Shima, et al. · PLoS ONE · 26
PDF
Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8+ T cell responses and promoting tertiary lymphoid structure formation
2026 · Kazutaka Hosoya, Hiroaki Ozasa, et al. · Nature Communications · 6
PDF
Longitudinal changes in mental health outcomes after COVID-19 hospitalization: A prospective study
2023 · Chigusa Shirakawa, Ryo Tachikawa, et al. · Respiratory Investigation · 4
PDF
Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective study
2025 · Yusuke Shima, Hironori Yoshida, et al. · BMC Cancer · 3
Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrence
2022 · Yusuke Shima, Yuki Sato, et al. · Investigational New Drugs · 3
PDF
Monocytes predict prognosis and successful treatment in older patients with miliary tuberculosis
2024 · Yusuke Shima, Takahiro Masuda, et al. · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2
Time dependency and unique etiology of barotrauma in COVID-19: A retrospective cohort study with landmark analysis and pathological approach
2023 · Takafumi Kabuto, Ryutaro Seo, et al. · PLoS ONE · 2
PDF
Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAF V600E Mutated Lung Adenocarcinoma via Survivin Downregulation
2025 · Kazutaka Hosoya, Hiroaki Ozasa, et al. · Cancer Science · 1
PDF
Successful treatment of lung cancer coexisting with B‑cell lymphoma with pembrolizumab following rituximab‑included chemotherapy: A case report
2024 · Daisuke Natori, Hiroaki Ozasa, et al. · Molecular and Clinical Oncology · 1
PDF
EGFR and MET protein expression in brain metastases of EGFR-mutated lung adenocarcinoma: Prognostic impact and comparison with primary tumors
2026 · Kazutaka Hosoya, Hiroaki Ozasa, et al. · International Journal of Lung Cancer
Abstract 369: Elucidation of intratumoral heterogeneity using patient-derived lung cancer cell line.
2026 · Tomoko Funazo, Hiroaki Ozasa, et al. · Cancer Research
Durvalumab consolidation after chemoradiotherapy for locoregional recurrent non‑small cell lung cancer
2025 · Keiichiro Suminaga, Hironori Yoshida, et al. · Molecular and Clinical Oncology
PDF
Abstract 1260: Establishment of intratumor heterogeneity models using lung cancer cells
2025 · Tomoko Funazo, Hiroaki Ozasa, et al. · Cancer Research
Abstract 4309: Establishment of intratumor heterogeneity using patient derived lung cancer cells
2024 · Tomoko Funazo, Hiroaki Ozasa, et al. · Cancer Research
Detection of a co-mutation in the epidermal growth factor receptor gene exon 20 H773L/V774M by FoundationOne test and treatment with osimertinib: A case report
2024 · Hiroshi Yoshida, Hiroaki Ozasa, et al. · Current Problems in Cancer Case Reports
Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients
2020 · Ryosuke Hirabayashi, Yusuke Takahashi, et al. · European Respiratory Journal
Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates
2020 · Megumu Osaki, Ryo Tachikawa, et al. · European Respiratory Journal
Works count: 17
Citation count: 48
H-index: 3
I10-index: 1
Year
Topic
Type